Literature DB >> 62668

Solubilization and molecular characterization of membrane-bound antigens shared by thymocytes and brain.

R Arndt, R Stark, P Klein, A Müller, H G Thiele.   

Abstract

In order to characterize chemically the serologically well-defined antigens shared by thymocytes and nervous tissue of mice and rats, different solubilization procedures have been tested. Treatment of thymocyte membranes with urea-Nonidet-P40 (NP40) proved to be the most valuable method, since nearly 100% of the antigen was solubilized essentially without loss of the antigenicity. By gel filtration in urea-NP40 the molecular weight was estimated to be 35 000 and the Stokes radius in sodium deoxycholate 31.8 A. In gel filtration studies a homogenous peak was obtained, whereas isoelectric focusing yielded two peaks (isoelectric points pH 4.5-5.0 and pH 5.4). The three determinants of this antigenic system were inseparable in gel filtration and isoelectric focusing, supporting the view put forward on the basis of serological studies that they are part of the same molecule. Extraction of murine thymocyte membranes with organic solvents yielded a considerable loss of activity of the thymocyte-brain antigen. There was some residual activity in the protein fraction, but none in the organic phase. Correspondingly, the highly purified ganglioside G Gtet 2b proved unable to absorb any rabbit anti-CBA brain serum. The reduced antigenic activity of the delipidated protein fraction could be restored by addition of lipids, as well as the nonionic detergent NP40. These observations suggest that interaction of protein and lipid is necessary for the antigenicity of the thymocyte-brain antigen.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 62668     DOI: 10.1002/eji.1830060506

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Partial molecular characterization of an antigenic structure associated to cells of common acute lymphocytic leukaemia (ALL).

Authors:  H Kabisch; R Arndt; H G Thiele; K Winkler; G Landbeck
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

2.  A human thy-1-like antigen expressed on cultured leukemic T-cells.

Authors:  F Saji; N Tanigaki
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

3.  Evidence for the presence of choleragen receptor on the thymocyte-brain antigen molecule of mice.

Authors:  H G Thiele; R Arndt; R Stark
Journal:  Immunology       Date:  1977-05       Impact factor: 7.397

4.  Use of a monoclonal antibody specifically non-reactive with T cells to delineate lymphocyte subpopulations.

Authors:  F Takei; D S Secher; C Milstein; T Springer
Journal:  Immunology       Date:  1981-03       Impact factor: 7.397

5.  Isolation and characterization of the thymus-brain antigen (analogous to thy-1 antigen) from human brain.

Authors:  A Hamann; R Arndt; P Klein; H G Thiele
Journal:  Biochem J       Date:  1980-05-01       Impact factor: 3.857

6.  Detection and molecular characterization of the thymus-brain antigen in human brain.

Authors:  R Arndt; R Stark; H G Thiele
Journal:  Immunology       Date:  1977-07       Impact factor: 7.397

7.  Independent mobility of cholera toxin binding sites and Thy-1 alloantigen on mouse thymocytes.

Authors:  D De Cicco; M F Greaves
Journal:  Immunology       Date:  1978-07       Impact factor: 7.397

8.  Serological and chromatographic analyses of antigenic structures detected in human brain, thymus and lymph nodes.

Authors:  R Arndt; R Stark; P Klein; H G Thiele
Journal:  Immunology       Date:  1978-07       Impact factor: 7.397

9.  Demonstration of Thy-1 antigen on pluripotent hemopoietic stem cells in the rat.

Authors:  I Goldschneider; L K Gordon; R J Morris
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

10.  Isolation and partial characterization of the human homologue of Thy-1.

Authors:  E W Ades; R K Zwerner; R T Acton; C M Balch
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.